SCHEMBL4264696

SCHEMBL4264696

NNc1ccc(Cc2ccc(NN)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP3A4 P08684 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
TSHR P16473 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
IDO1 P14902 1/20 0.48
CYP2C19 P33261 1/20 0.48
PTGS2 P35354 1/20 0.48
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7597445 0.95 LMNA (0.43) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL17705702 0.90 ALDH1A1 (0.43) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL17705699 0.90 CYP3A4 (0.67) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL486301 0.90 IDO1 (0.59) LMNAALDH1A1CYP3A4TDP1TSHR
Hydrochloric Acid SCHEMBL4381619 0.88 CYP3A4 (0.56) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL15247738 0.81 NOS3 (0.40) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL218054 0.80 TDP1 (0.67) LMNAALDH1A1CYP3A4TDP1TSHR
SCHEMBL22990410 0.80 HRH3 (0.52) LMNACYP3A4TDP1CYP1A2CYP2D6
SCHEMBL9593311 0.78 TBXAS1 (0.51) ALDH1A1CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL1143908 0.78 TAAR1 (0.48) LMNAALDH1A1CYP3A4TDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130178437-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-11 US disclosed
US-20130178437-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-11 US disclosed
WO-2012004007-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-01-12 WO disclosed
US-20090035491-A1 Ink-Jet Recording Material MITSUBISHI PAPER MILLS LIMITED (JP) 2009-02-05 US disclosed
US-5091466-A Insolubilization of soluble pre-imidized polyimides by polyhydrazine compounds GENERAL ELECTRIC COMPANY (US) 1992-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178437-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION SI, HASPIN, HPN LMNA 57/4885ALDH1A1 840/4885CYP3A4 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.